Stock listing
NASDAQ:OMCL Omnicell, Inc. Stock
Home listing (NASDAQ) of Omnicell, Inc.
Follow Omnicell, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:OMCL
$32.51 USD -2.15 (-6.2%)
Close on Nov 20, 2026
- Day range
- $32.27 – $33.39 USDNov 20, 2026
- Volume
- 564,519 sharesNov 20, 2026
- Market cap
- $1.50B USDAt the close on Nov 20, 2026 · price × 46.00M shares outstanding
- 52-week range
- $31.75 – $55.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $19.77M USDMedian day 534,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:OMCL · Home | $32.51 USD | -2.15 (-6.2%) | 564,519 | $32.93 | $33.39 | $32.27 | $34.66 | Close on Nov 20, 2026 |
| Frankfurt:OC9 | €29.20 EUR | -2.00 (-6.4%) | — | €29.60 | €29.60 | €29.20 | €31.20 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:OMCL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $32.51 | -2.15 | -6.2% | $32.93 | $33.39 | $32.27 | 564,519 | |
| $34.66 | +0.66 | +1.9% | $34.26 | $34.88 | $33.65 | 341,291 | |
| $34.00 | -1.44 | -4.1% | $35.25 | $35.25 | $33.80 | 482,276 | |
| $35.44 | +0.41 | +1.2% | $34.88 | $35.56 | $34.45 | 445,783 | |
| $35.03 | +0.08 | +0.2% | $35.06 | $35.19 | $34.59 | 313,243 | |
| $34.95 | -0.62 | -1.7% | $35.60 | $35.85 | $34.82 | 273,789 | |
| $35.57 | -0.33 | -0.9% | $35.79 | $36.18 | $35.29 | 418,403 | |
| $35.90 | -1.45 | -3.9% | $37.00 | $37.06 | $34.96 | 560,174 | |
| $37.35 | +0.01 | 0.0% | $37.88 | $38.25 | $37.26 | 495,780 | |
| $37.34 | -0.69 | -1.8% | $37.48 | $37.77 | $36.40 | 562,784 | |
| $38.03 | -1.38 | -3.5% | $39.78 | $40.10 | $37.13 | 783,281 | |
| $39.41 | +3.95 | +11.1% | $36.54 | $39.63 | $36.54 | 850,493 | |
| $35.46 | -0.95 | -2.6% | $36.33 | $36.96 | $35.19 | 890,821 | |
| $36.41 | -0.24 | -0.7% | $36.78 | $37.59 | $36.23 | 1,078,689 | |
| $36.65 | -0.23 | -0.6% | $37.13 | $37.30 | $35.50 | 785,542 | |
| $36.88 | +0.93 | +2.6% | $35.83 | $38.50 | $35.81 | 841,709 | |
| $35.95 | -0.81 | -2.2% | $36.83 | $37.50 | $35.45 | 936,895 | |
| $36.76 | -0.21 | -0.6% | $36.94 | $37.85 | $36.49 | 580,980 | |
| $36.97 | -0.78 | -2.1% | $37.73 | $37.83 | $36.75 | 539,718 | |
| $37.75 | +0.65 | +1.8% | $36.87 | $37.83 | $36.60 | 754,700 | |
| $37.10 | +0.76 | +2.1% | $36.40 | $37.64 | $36.34 | 428,900 | |
| $36.34 | -0.15 | -0.4% | $36.07 | $37.21 | $35.59 | 459,100 | |
| $36.49 | +0.68 | +1.9% | $36.10 | $36.80 | $36.01 | 444,800 | |
| $35.81 | +0.42 | +1.2% | $35.39 | $36.20 | $35.12 | 426,300 | |
| $35.39 | -0.56 | -1.6% | $36.12 | $36.52 | $35.08 | 426,700 | |
| $35.95 | +0.56 | +1.6% | $35.45 | $36.23 | $35.23 | 393,000 | |
| $35.39 | -1.06 | -2.9% | $36.13 | $36.41 | $35.07 | 385,700 | |
| $36.45 | -0.42 | -1.1% | $37.02 | $37.32 | $36.05 | 400,700 | |
| $36.87 | +1.05 | +2.9% | $35.87 | $37.17 | $35.59 | 459,000 | |
| $35.82 | +0.99 | +2.8% | $35.25 | $36.05 | $35.17 | 303,100 | |
| $34.83 | -0.38 | -1.1% | $34.89 | $35.06 | $34.43 | 509,500 | |
| $35.21 | -0.25 | -0.7% | $35.05 | $35.94 | $34.91 | 570,600 | |
| $35.46 | +0.82 | +2.4% | $34.95 | $35.56 | $34.24 | 634,200 | |
| $34.64 | +1.04 | +3.1% | $33.07 | $34.72 | $33.07 | 397,600 | |
| $33.60 | +0.16 | +0.5% | $33.93 | $33.96 | $33.41 | 344,500 | |
| $33.44 | -0.61 | -1.8% | $34.02 | $34.27 | $33.18 | 449,400 | |
| $34.05 | -0.26 | -0.8% | $34.26 | $34.46 | $33.71 | 592,500 | |
| $34.31 | +0.44 | +1.3% | $33.88 | $34.38 | $33.31 | 573,463 | |
| $33.87 | +0.21 | +0.6% | $33.21 | $33.95 | $32.70 | 563,603 | |
| $33.66 | +0.63 | +1.9% | $33.05 | $33.73 | $32.63 | 508,400 | |
| $33.03 | +0.04 | +0.1% | $33.01 | $33.23 | $32.60 | 499,200 | |
| $32.99 | -0.18 | -0.5% | $33.17 | $33.58 | $32.40 | 437,000 | |
| $33.17 | +0.74 | +2.3% | $32.86 | $33.47 | $32.72 | 547,200 | |
| $32.43 | +0.20 | +0.6% | $32.43 | $32.57 | $31.98 | 434,900 | |
| $32.23 | -0.39 | -1.2% | $32.49 | $32.62 | $32.04 | 937,200 | |
| $32.62 | +0.19 | +0.6% | $32.76 | $33.22 | $32.26 | 394,300 | |
| $32.43 | -0.20 | -0.6% | $32.79 | $33.17 | $32.20 | 439,300 | |
| $32.63 | -0.88 | -2.6% | $33.13 | $33.35 | $32.23 | 642,600 | |
| $33.51 | +0.72 | +2.2% | $33.23 | $33.63 | $32.91 | 395,700 | |
| $32.79 | +0.54 | +1.7% | $32.88 | $33.02 | $32.32 | 483,600 | |
| $32.25 | -1.39 | -4.1% | $33.26 | $33.37 | $32.12 | 534,300 | |
| $33.64 | -0.24 | -0.7% | $33.49 | $33.68 | $32.83 | 467,900 | |
| $33.88 | -0.49 | -1.4% | $33.75 | $35.30 | $33.54 | 571,100 | |
| $34.37 | -0.45 | -1.3% | $34.36 | $34.70 | $34.00 | 873,100 | |
| $34.82 | +0.11 | +0.3% | $35.09 | $35.38 | $34.41 | 673,300 | |
| $34.71 | +0.20 | +0.6% | $34.51 | $35.29 | $34.26 | 634,500 | |
| $34.51 | -0.65 | -1.8% | $34.70 | $35.61 | $34.07 | 805,500 | |
| $35.16 | +2.08 | +6.3% | $32.82 | $35.22 | $32.53 | 1,038,000 | |
| $33.08 | -0.33 | -1.0% | $33.52 | $33.76 | $32.87 | 538,700 | |
| $33.41 | -0.04 | -0.1% | $33.38 | $33.79 | $33.21 | 436,700 | |
| $33.45 | +0.23 | +0.7% | $33.22 | $33.88 | $32.96 | 627,200 | |
| $33.22 | -1.44 | -4.2% | $34.91 | $34.91 | $33.16 | 667,014 | |
| $34.66 | -0.92 | -2.6% | $35.56 | $35.66 | $34.44 | 512,006 | |
| $35.58 | +0.08 | +0.2% | $35.72 | $35.95 | $35.17 | 777,100 | |
| $35.50 | -0.93 | -2.6% | $36.21 | $36.55 | $35.30 | 582,100 |
- Ticker
- NASDAQ:OMCL
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Omnicell Announces Third Quarter 2026 Financial Results
Latest earnings call · Oct 29, 2026
Omnicell (NASDAQ:OMCL) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Apr 28, 2026
Q1 2026 Earnings Presentation
Earnings · 33 slides
Latest news
Omnicell Announces Third Quarter 2026 Financial Results
Oct 29, 2026
Closed $36.88 (+2.6%) on Oct 29, 2026
Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026
Oct 8, 2026
Closed $35.82 (+2.8%) on Oct 9, 2026
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
Aug 31, 2026
Closed $34.51 (-1.8%) on Sep 1, 2026
Omnicell Announces Second Quarter 2026 Financial Results
Jul 30, 2026
Closed $37.11 (-10.4%) on Jul 30, 2026
Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
Jul 13, 2026
Closed $45.94 (-1.6%) on Jul 14, 2026
Nnamdi Njoku Appointed President of Omnicell
Jul 1, 2026
Closed $41.93 (+1.0%) on Jul 1, 2026
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business
Jun 8, 2026
Closed $41.95 (-2.4%) on Jun 8, 2026
Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
Jun 2, 2026
Closed $41.89 (0.0%) on Jun 3, 2026
Omnicell to Present at the BofA Securities 2026 Healthcare Conference
May 4, 2026
Closed $43.56 (+0.3%) on May 5, 2026
Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer
Apr 29, 2026
Closed $43.10 (-5.3%) on Apr 29, 2026
Omnicell, Inc. on 6ix
- News releases
- 16 in the last 12 months · 159 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Oct 29, 2026
- Decks
- 34 decks · latest Apr 28, 2026
Where Omnicell, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:OMCL · Home listing · This page | NASDAQ | United States | USD |
| gettex:OC9 | gettex | Germany | EUR |
| BOATS:OMCL | BOATS | United States | USD |
| LS Exchange:632313 | LS Exchange | Germany | EUR |
| BMV:OMCL | BMV | Mexico | MXN |
| Lang & Schwarz:632313 | Lang & Schwarz | Germany | EUR |
| BIVA:OMCL | BIVA | Mexico | MXN |
| BX Swiss:OC9 | BX Swiss | Switzerland | CHF |
| Dusseldorf:OC9 | Dusseldorf | Germany | EUR |
| Frankfurt:OC9 | Frankfurt | Germany | EUR |
| Hamburg:OC9 | Hamburg | Germany | EUR |
| Munich:OC9 | Munich | Germany | EUR |
| Stuttgart:OC9 | Stuttgart | Germany | EUR |
| Tradegate:OC9 | Tradegate | Germany | EUR |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.18B USD
- P/E
- 33.5×
- EV/sales
- 0.9×
- EV/EBITDA
- 8.4×
- Price/book
- 1.1×
- Gross margin
- 45.1%
- Operating margin
- 5.2%
- Net margin
- 3.6%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.06
Forecasts
6 strong buy · 1 buy · 1 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 57.43 USD · Analysts' mean
- EPS, year to Dec 2026
- 2.48 · 8 analysts
- Revenue, year to Dec 2026
- 1.23B · 8 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Randall Lipps | Chairman, Chief Executive Officer, and Founder |
| Baird Radford | Executive Vice President, Chief Financial Officer |
| Nnamdi Njoku | President and Chief Operating Officer |
| Corey Manley | Executive Vice President, Chief Legal and Administrative Officer |
| Kathleen Nemeth | Senior Vice President, Investor Relations |
| Alex Pratt | Senior Vice President, Chief Growth Officer |
| Dan Mandoli | Senior Vice President & General Manager, Specialty Pharmacy Services |
| Dave Ford | Senior Vice President, Chief People Officer |
| Gail Schroeder | Senior Vice President, Quality and Product Regulatory |
| Jason Woosley | Senior Vice President, Chief Product & Technology Officer |
| Martha Thorne | Senior Vice President and General Manager, EnlivenHealth |
| Michael McNeil | Senior Vice President, Chief Information Security Officer |
| Perry Genova | Senior Vice President, Chief Technology Officer |
| Rick Couldry | Senior Vice President, Chief Pharmacy and Clinical Officer |
| Stella Prefach | Senior Vice President, Chief Marketing Officer |
| Tomer Stavitsky | Senior Vice President, Chief Corporate Development Officer |
| Vicki MacDevitt | Chief of Staff |
Board
| Director | Role |
|---|---|
| Randall Lipps | Chairman, Chief Executive Officer, and Founder |
| Betsy Martinelli | Director |
| Bobby Ghoshal | Board Member |
| Bruce E. Scott | Board Member |
| Edward Bousa | Board Member |
| Eileen Voynick | Board Member |
| Joanne Bauer | Board Member |
| Mark Parrish | Board Member |
| Mary Garrett | Board Member |
| Rob Seim | Board Member |
Events
Calls
| Call | When | Status |
|---|---|---|
| Omnicell (NASDAQ:OMCL) Q3 2026 Earnings Call | Thu, Oct 29, 2026 · 8:30 AM ET | Replay |
| Omnicell (NASDAQ:OMCL) Q2 2026 Earnings Call | Thu, Jul 30, 2026 · 8:30 AM ET | Replay |
| Omnicell (NASDAQ:OMCL) Q1 2026 Earnings Call | Tue, Apr 28, 2026 · 8:30 AM ET | Replay |
| Omnicell (NASDAQ:OMCL) Q4 2025 Earnings Call | Thu, Feb 05, 2026 · 8:30 AM ET | Replay |
| Omnicell (NASDAQ:OMCL) Q3 2025 Earnings Call | Thu, Oct 30, 2025 · 8:30 AM ET | Replay |
| Omnicell (NASDAQ:OMCL) Q2 2025 Earnings Call | Thu, Jul 31, 2025 · 8:30 AM ET | Replay |
| Omnicell (NASDAQ:OMCL) Q1 2025 Earnings Call | Tue, May 06, 2025 · 8:30 AM ET | Replay |
| Omnicell (NASDAQ:OMCL) Q4 2024 Earnings Call | Thu, Feb 06, 2025 · 8:30 AM ET | Replay |
| Omnicell (NASDAQ:OMCL) Q3 2024 Earnings Call | Wed, Oct 30, 2024 · 8:30 AM ET | Replay |
| Omnicell (NASDAQ:OMCL) Q2 2024 Earnings Call | Thu, Aug 01, 2024 · 8:30 AM ET | Replay |
All 24 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 29, 2026 · Before open | +2.6% |
| Q2 2026 | Jul 30, 2026 · Before open | −10.4% |
| Q1 2026 | Apr 28, 2026 · Before open | +20.9% |
| Q4 2025 | Feb 5, 2026 · Before open | −16.3% |
| Q3 2025 | Oct 30, 2025 · Before open | +13.6% |
| Q2 2025 | Jul 31, 2025 · Before open | +4.4% |
| Q1 2025 | May 6, 2025 · Before open | −15.8% |
| Q4 2024 | Feb 6, 2025 · Before open | −11.2% |
| Q3 2024 | Oct 30, 2024 · Before open | +32.2% |
| Q2 2024 | Aug 1, 2024 · Before open | +33.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 2, 2024 · Before open | +7.8% |
| Q4 2023 | Feb 8, 2024 · Before open | −10.3% |
| Q3 2023 | Nov 2, 2023 · Before open | −18.3% |
| Q2 2023 | Aug 1, 2023 · After close | +4.7% |
| Q1 2023 | May 2, 2023 · After close | +14.5% |
| Q4 2022 | Feb 28, 2023 · After close | +5.0% |
| Q3 2022 | Nov 2, 2022 · Before open | −34.5% |
| Q2 2022 | Aug 4, 2022 · After close | −1.4% |
| Q1 2022 | Apr 28, 2022 · After close | +1.6% |
| Q4 2021 | Feb 14, 2022 · After close | −5.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 2026 Earnings Presentation | Earnings | 33 slides | Apr 28, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 36 slides | Feb 5, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 35 slides | Oct 30, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 37 slides | Jul 31, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 36 slides | May 6, 2025 |
| FY2024 Earnings Presentation | Earnings | 37 slides | Feb 6, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 37 slides | Feb 6, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 27 slides | Oct 30, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 25 slides | Aug 1, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 24 slides | May 2, 2024 |
All 34 decks
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.11B | 1.15B | 1.30B | 1.13B | 892.2M | 897.0M | 787.3M | 712.7M | 695.9M |
| Cost of revenue | 681.4M | 641.2M | 650.3M | 707.0M | 577.4M | 478.9M | 460.1M | 415.0M | 394.1M | 378.8M |
| Gross profit | 503.4M | 471.0M | 496.8M | 589.0M | 554.7M | 413.3M | 436.9M | 372.3M | 318.6M | 317.1M |
| Research and development | 88.7M | 90.4M | 97.1M | 105.0M | 75.7M | 70.2M | 68.6M | 64.8M | 66.0M | 57.8M |
| Selling, general and administrative | 409.6M | 380.3M | 434.6M | 486.3M | 389.4M | 307.6M | 289.9M | 263.1M | 241.5M | 237.9M |
| Operating income | 5.16M | 337.0K | -34.9M | -2.32M | 89.5M | 35.5M | 78.4M | 44.4M | 11.1M | 21.4M |
| Depreciation and amortization | 78.8M | 82.2M | 87.3M | 86.9M | 73.0M | 61.1M | 53.6M | 51.4M | 51.5M | 58.4M |
| EBITDA | 84.0M | 82.6M | 52.5M | 84.6M | 162.5M | 96.6M | 131.9M | 95.7M | 62.7M | 79.8M |
| Interest expense | 3.60M | 7.50M | 6.30M | 5.30M | ||||||
| Income before tax | 11.3M | 25.6M | -20.1M | -2.45M | 66.0M | 29.3M | 73.9M | 35.6M | 4.51M | 13.0M |
| Income tax | 9.27M | 13.1M | 263.0K | -8.10M | -11.8M | -2.85M | 12.6M | -2.11M | -26.0M | 3.22M |
| Net income | 2.05M | 12.5M | -20.4M | 5.65M | 77.8M | 32.2M | 61.3M | 37.7M | 30.5M | 9.76M |
| Earnings per share, basic | 0.04 | 0.27 | -0.45 | 0.13 | 1.79 | 0.76 | 1.48 | 0.96 | 0.81 | 0.27 |
| Earnings per share, diluted | 0.04 | 0.27 | -0.45 | 0.12 | 1.62 | 0.74 | 1.43 | 0.93 | 0.79 | 0.26 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 196.5M | 369.2M | 468.0M | 330.4M | 349.1M | 485.9M | 127.2M | 67.2M | 32.4M | 54.5M |
| Receivables | 216.9M | 256.4M | 252.0M | 299.5M | 240.9M | 190.1M | 218.4M | 196.2M | 190.0M | 150.3M |
| Inventory | 100.9M | 88.7M | 110.1M | 147.5M | 119.9M | 96.3M | 108.0M | 100.9M | 96.1M | 69.3M |
| Current assets | 680.1M | 815.5M | 927.6M | 881.8M | 780.7M | 829.4M | 483.2M | 397.1M | 352.3M | 315.4M |
| Property, plant and equipment | 120.1M | 112.7M | 108.6M | 94.0M | 71.1M | 59.1M | 54.2M | 51.5M | 42.6M | 42.0M |
| Goodwill | 737.9M | 734.7M | 735.8M | 734.3M | 738.9M | 499.3M | 336.5M | 335.9M | 337.8M | 327.7M |
| Total assets | 1.97B | 2.12B | 2.23B | 2.21B | 2.14B | 1.82B | 1.24B | 1.08B | 1.02B | 935.1M |
| Accounts payable | 44.0M | 51.8M | 45.0M | 63.4M | 71.5M | 40.3M | 46.4M | 38.0M | 48.3M | 27.1M |
| Current liabilities | 476.6M | 595.7M | 367.8M | 428.4M | 876.2M | 276.4M | 237.0M | 204.6M | 205.2M | 180.9M |
| Long-term debt | 50.0M | 135.4M | 194.9M | 245.7M | ||||||
| Total debt | 50.0M | 140.0M | 210.1M | 254.1M | ||||||
| Total liabilities | 742.9M | 877.6M | 1.04B | 1.08B | 995.8M | 857.0M | 395.6M | 401.6M | 462.0M | 503.5M |
| Shareholders' equity | 1.23B | 1.24B | 1.19B | 1.13B | 1.15B | 967.5M | 845.3M | 679.6M | 554.3M | 458.8M |
| Shares outstanding | 45.0M | 46.4M | 45.5M | 44.7M | 44.2M | 42.8M | 42.1M | 40.3M | 38.4M | 36.6M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 127.3M | 187.7M | 181.1M | 77.8M | 231.8M | 185.9M | 145.0M | 104.0M | 24.8M | 49.9M |
| Capital spending | -40.4M | -36.5M | -41.5M | -47.5M | -29.0M | -22.8M | -15.9M | -23.7M | -15.3M | -13.4M |
| Free cash flow | 86.9M | 151.3M | 139.6M | 30.2M | 202.8M | 163.0M | 129.1M | 80.3M | 9.49M | 36.5M |
| Cash from investing | -60.4M | -52.8M | -55.0M | -58.7M | -412.5M | -279.9M | -61.7M | -54.4M | -35.0M | -341.3M |
| Cash from financing | -218.3M | -235.6M | 23.4M | -21.0M | 47.4M | 456.3M | -23.5M | -13.6M | -9.88M | 263.8M |
| Share buybacks | -77.6M | 0 | 0 | -52.2M | 0 | -53.0M | 0 | 0 | 0 | 0 |
| Change in cash | -147.6M | -102.4M | 148.1M | -2.79M | -134.3M | 362.7M | 60.0M | 34.8M | -22.1M | -27.7M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 4, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 29, 2026 | Results | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 17, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 10, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 30, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 15, 2026 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Jul 7, 2026 | Offer document | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 8-K · Current report | Jul 1, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 8-K · Current report | May 26, 2026 | Management or board change | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 18, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 18, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | May 15, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 6, 2026 | Quarterly report | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Apr 28, 2026 | Results | SEC |
| ARS · Annual report to shareholders | Apr 13, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 13, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Apr 2, 2026 | Meeting notice | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 1, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 16, 2026 | Other filings | SEC |
| 10-K · Annual report | Feb 26, 2026 | Annual report | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 17, 2026 | Other filings | SEC |
| 8-K · Current report | Feb 5, 2026 | Results | SEC |
| 4 · Change in ownership | Jan 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 8, 2026 | Other filings | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 16, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 8, 2025 | Current report | SEC |
| 4 · Change in ownership | Dec 5, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 3, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 17, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 30, 2025 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 9, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Oct 6, 2025 | Current report | SEC |
| 4 · Change in ownership | Sep 16, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 12, 2025 | Other filings | SEC |
| 3 · Initial statement of ownership | Sep 5, 2025 | Insider trade | SEC |
| 8-K · Current report | Aug 25, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 31, 2025 | Results | SEC |
| S-8 · Registration statement for employee plans | Jun 18, 2025 | Offer document | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 5, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 8-K · Current report | May 23, 2025 | Management or board change | SEC |
| SD · Specialized disclosure | May 22, 2025 | ESG report | SEC |
| 8-K · Current report | May 22, 2025 | Current report | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 28, 2025 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 3, 2025 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 3, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 18, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 12, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 11, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 4, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 10-K · Annual report | Feb 27, 2025 | Annual report | SEC |
| 4 · Change in ownership | Feb 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 6, 2025 | Results | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 12, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 10, 2024 | Other filings | SEC |
| 8-K · Current report | Nov 25, 2024 | Material contract | SEC |
| 4 · Change in ownership | Nov 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2024 | Insider trade | SEC |
| 8-K · Current report | Nov 18, 2024 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 8, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 30, 2024 | Results | SEC |
| 3 · Initial statement of ownership | Oct 11, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 25, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Sep 16, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 6, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 1, 2024 | Results | SEC |
| S-8 · Registration statement for employee plans | Jun 21, 2024 | Offer document | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2024 | Insider trade | SEC |
| 8-K/A · Current report, amended | Jun 4, 2024 | Management or board change | SEC |
| 8-K · Current report | May 24, 2024 | Management or board change | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 17, 2024 | Insider trade | SEC |
| SD · Specialized disclosure | May 14, 2024 | ESG report | SEC |
| 10-Q · Quarterly report | May 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 2, 2024 | Results | SEC |
| ARS · Annual report to shareholders | Apr 11, 2024 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 4, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 29, 2024 | Insider trade | SEC |
| 8-K · Current report | Feb 29, 2024 | Management or board change | SEC |
| 10-K · Annual report | Feb 28, 2024 | Annual report | SEC |
| 4 · Change in ownership | Feb 16, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 8, 2024 | Results | SEC |
| 4 · Change in ownership | Feb 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 1, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 19, 2024 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Jan 16, 2024 | Insider trade | SEC |
| 8-K · Current report | Jan 11, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Dec 18, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 18, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 18, 2023 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Dec 11, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 17, 2023 | Insider trade | SEC |
| 8-K · Current report | Nov 9, 2023 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 3, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 2, 2023 | Results | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Omnicell, Inc.’s releases · as of Oct 28, 2026
- Common shares
- 45,995,034
- Fully diluted
- 45,995,034
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 45,995,034 | Oct 28, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 28, 2026 | 45,995,034 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joseph E. Whitters Other companies: Accuray Incorporated (Director · Since at least Jul 16, 2018); Spark Networks SE (Director · Aug 11, 2021 – Dec 13, 2021 · Past); Cutera Inc (Director · Feb 19, 2019 – Jun 16, 2022 · Past); Analogic Corporation (Director · Oct 13, 2017 – Jun 22, 2018 · Past); Air Methods Corp (Director · Mar 22, 2016 – Apr 21, 2017 · Past); PRGX Global Inc (Director · Jan 14, 2013 – Mar 3, 2021 · Past); InfuSystems Holdings, Inc. (Director · Apr 24, 2012 – Aug 23, 2018 · Past); Solexa Inc (Director · Jul 28, 2006 – Jan 26, 2007 · Past); Luminent Mortgage Capital Inc (Director · Mar 15, 2006 – Dec 27, 2007 · Past); Mentor Corp (Director · Oct 5, 2005 – Sep 15, 2008 · Past) | Director · Feb 3, 2006 – Nov 8, 2012 · Past |
| Edward Bousa Other companies: Gartner, Inc. (Director · Since at least Jan 29, 2026); Corebridge Financial Inc. (Director · Since at least Aug 24, 2024); Azenta, Inc. (Director · Jan 30, 2024 – Feb 12, 2024 · Past) | Board Member · Since at least Jul 7, 2021 |
| Mark Parrish Other companies: Viatris Inc. (Director · Since at least Nov 16, 2020); Bausch Health Companies Inc. (Director · Jan 1, 2010 – Jul 5, 2010 · Past); Cardinal Health, Inc. (CEO - HSCS · Nov 8, 2006 – Sep 2, 2007 · Past) | Board Member · Since at least Jan 1, 2013 |
| Mary Garrett Other companies: PROCEPT BioRobotics Corporation (CHAIR OF THE NOMINATING AND ESG COMMITTEE · Since at least Dec 29, 2021); Hill-Rom Holdings Inc (Director · Mar 14, 2017 – Dec 13, 2021 · Past); Ethan Allen Interiors Inc. (Director · Jan 5, 2016 – Aug 3, 2021 · Past) | Board Member · Since at least May 24, 2022 |
| Gary S. Petersmeyer Other companies: The Cooper Companies, Inc. (Director · Since at least Jan 25, 2013); Dextera Surgical Inc (Director · Oct 10, 2014 – Dec 19, 2014 · Past) | Director · Jan 3, 2007 – May 14, 2019 · Past |
| Harlan Baird Radford Other companies: Allakos Inc (Chief Financial Officer · Apr 19, 2021 – May 15, 2025 · Past); eBay Inc. (VP Corp Controller & Inter CAO · May 24, 2007 – Mar 1, 2008 · Past) | EVP & Chief Financial Officer · Since at least Aug 26, 2025 |
| Kevin L Roberg Other companies: Compellent Technologies Inc (Director · Apr 12, 2010 – Feb 22, 2011 · Past); Thomas & Betts Corp (Director · May 2, 2007 – May 16, 2012 · Past) | Director · Aug 15, 2005 – Oct 25, 2006 · Past |
| Nchacha E. Etta Other companies: U.S. Physical Therapy, Inc. (Executive Vice President and Chief Financial Officer · Since at least Sep 1, 2026); KBR, Inc. (Director · Since at least Aug 12, 2024) | EVP & CFO · Since at least Jun 1, 2023 |
| Peter J Kuipers Other companies: Clover Health Investments, Corp. (Chief Financial Officer · Since at least May 8, 2024); Invacare Corporation (Director · May 5, 2023 – Nov 1, 2023 · Past) | EVP, EXECUTIVE ADVISOR · Aug 24, 2015 – Jun 15, 2023 · Past |
| Bobby Ghoshal Other companies: ResMed Inc. (President and Chief Operating Officer · Aug 1, 2025 – Nov 4, 2026 · Past) | Board Member · Since at least Nov 4, 2026 |
All 54 people
| Person | Seat |
|---|---|
| Brian H Nutt Other companies: Covance Inc (Principal Accounting Officer · May 12, 2011 – Feb 19, 2015 · Past) | VP, Chief Accounting Officer · Since at least May 14, 2024 |
| Donald C Wegmiller Other companies: Possis Medical Inc (Director · Jan 3, 2006 – Apr 2, 2008 · Past) | Director · Dec 31, 2005 – Aug 12, 2013 · Past |
| Eileen Voynick Other companies: CDK Global Holdings LLC (Director · Sep 6, 2016 – Jul 6, 2022 · Past) | Board Member · Since at least Jan 5, 2024 |
| James T Judson Other companies: Extreme Networks, Inc. (Interim CFO · Mar 16, 2011 – Sep 28, 2012 · Past) | Director · Sep 1, 2006 – Aug 24, 2021 · Past |
| Joanne Bauer Other companies: Kimberly-Clark Corporation (President, K-C Healthcare · Apr 25, 2010 – May 27, 2014 · Past) | Board Member · Since at least Jan 1, 2014 |
| John D Stobo Jr Other companies: American Public Education, Inc. (Director · Nov 8, 2007 – Mar 3, 2008 · Past) | Director · Feb 8, 2006 – Feb 8, 2006 · Past |
| Kaushik Ghoshal Other companies: ResMed Inc. (Chief Commercial Officer, SaaS · Since at least Aug 18, 2022) | Director · Since at least Jul 6, 2023 |
| Marga Ortigas-Wedekind Other companies: HeartBeam, Inc. (Director · Since at least Nov 10, 2021) | Vice President, Marketing · Jan 12, 2009 – Mar 31, 2015 · Past |
| Alex Pratt | Senior Vice President, Chief Growth Officer · Since at least Nov 4, 2026 |
| Baird Radford | Executive Vice President, Chief Financial Officer · Since at least Dec 1, 2025 |
| Betsy Martinelli | Director · Since at least Apr 29, 2026 |
| Bruce D Smith | Director · May 20, 2014 – May 25, 2021 · Past |
| Bruce E. Scott | Board Member · Since at least May 14, 2019 |
| Corey Manley | Executive Vice President, Chief Legal and Administrative Officer · Since at least May 11, 2022 |
| Dan Mandoli | Senior Vice President & General Manager, Specialty Pharmacy Services · Since at least Jul 30, 2026 |
| Dan S Johnston | EVP, EXECUTIVE ADVISOR · Jun 15, 2022 – Jun 15, 2022 · Past |
| Dave Ford | Senior Vice President, Chief People Officer · Since at least Nov 4, 2026 |
| Gail Schroeder | Senior Vice President, Quality and Product Regulatory · Since at least Nov 5, 2026 |
| Gary E Wright | Exec VP Sales · Feb 28, 2006 – Feb 28, 2006 · Past |
| Jason Woosley | Senior Vice President, Chief Product & Technology Officer · Since at least Nov 5, 2026 |
| J Christopher Drew | President, North American A&A · May 8, 2006 – Jun 5, 2018 · Past |
| John Choma | VP, Professional Svcs & CLO · Feb 7, 2007 – Jul 1, 2009 · Past |
| Jorge R Taborga | EVP, Global R & D · Feb 16, 2013 – Mar 11, 2019 · Past |
| Joseph Brian Spears | Executive Advisor · Jan 30, 2018 – May 15, 2024 · Past |
| Kathleen Nemeth | Senior Vice President, Investor Relations · Since at least Feb 5, 2026 |
| Martha Thorne | Senior Vice President and General Manager, EnlivenHealth · Since at least Nov 5, 2026 |
| Michael D Stevenson | Exec. VP, Global Manufacturing · Feb 16, 2013 – Dec 16, 2013 · Past |
| Michael McNeil | Senior Vice President, Chief Information Security Officer · Since at least Nov 5, 2026 |
| Nhat H Ngo | EVP, Marketing, S & B D · Nov 3, 2008 – Feb 18, 2021 · Past |
| Nnamdi Njoku | President & COO · Since at least Oct 7, 2024 |
| Perry Genova | Senior Vice President, Chief Technology Officer · Since at least Mar 24, 2025 |
| Randall Lipps | CHAIRMAN, CEO, Director · Since at least Dec 15, 2023 |
| Randy D Lindholm | Director · Apr 26, 2006 – Oct 7, 2016 · Past |
| Renee M Luhr | VP Sales · Mar 9, 2006 – Dec 31, 2008 · Past |
| Rick Couldry | Senior Vice President, Chief Pharmacy and Clinical Officer · Since Apr 29, 2026 · Appointed, no departure found |
| Rick Couldry | Senior Vice President, Chief Pharmacy and Clinical Officer · Since at least Jul 30, 2026 |
| Robin Gene Seim | Director · Since at least Jul 1, 2015 |
| Rob Seim | Board Member · Since at least Nov 4, 2026 |
| Sara J White | Director · Oct 31, 2005 – May 23, 2023 · Past |
| Scott Peter Seidelmann | EVP, EXECUTIVE ADVISOR · Apr 2, 2018 – Jun 15, 2023 · Past |
| Stella Prefach | Senior Vice President, Chief Marketing Officer · Since at least Nov 5, 2026 |
| Tomer Stavitsky | Senior Vice President, Chief Corporate Development Officer · Since at least Nov 5, 2026 |
| Vance B Moore | Director · May 22, 2012 – May 23, 2023 · Past |
| Vicki MacDevitt | Chief of Staff · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Omnicell, Inc.